GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 39.56
+0.31 (0.79%)
At close: Mar 27, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.26 billion as of April 3, 2025. Its market cap has increased by 5.15% in one year.
Market Cap
3.26B
Enterprise Value
3.30B
Revenue
2.99B
Ranking
n/a
PE Ratio
18.72
Stock Price
39.56
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.26B, an increase of 471.96%. That is a compound annual growth rate of 9.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 250.91B |
| El Sewedy Electric Company | 174.36B |
| Talaat Moustafa Group Holding | 109.58B |
| Eastern Company S.A.E | 99.75B |
| Misr Fertilizer Production Company | 84.77B |
| Egypt Aluminum | 71.98B |
| Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 71.75B |
| Qatar National Bank | 64.58B |